-
Je něco špatně v tomto záznamu ?
Brain MRI disease burden and sex differences in cognitive performance of patients with multiple sclerosis
J. Motyl, L. Friedova, R. Ganapathy Subramanian, M. Vaneckova, TA. Fuchs, J. Krasensky, J. Blahova Dusankova, E. Kubala Havrdova, D. Horakova, T. Uher
Jazyk angličtina Země Itálie
Typ dokumentu časopisecké články
Grantová podpora
NV18-08-00062
Ministerstvo Zdravotnictví Ceské Republiky
RVO VFN 64165
Ministerstvo Zdravotnictví Ceské Republiky
project Cooperatio LF1, research area Neuroscience
Ministerstvo Školství, Mládeže a Tělovýchovy
Programme EXCELES, ID project No LX22NPO5107
European Commission
1154218
Grantová Agentura, Univerzita Karlova
- MeSH
- kognice MeSH
- kognitivní dysfunkce * MeSH
- kognitivní poruchy * diagnóza MeSH
- lidé MeSH
- magnetická rezonanční tomografie MeSH
- mozek diagnostické zobrazování MeSH
- neuropsychologické testy MeSH
- pohlavní dimorfismus MeSH
- roztroušená skleróza * komplikace diagnostické zobrazování MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Although there is evidence that shows worse cognitive functioning in male patients with multiple sclerosis (MS), the role of brain pathology in this context is under-investigated. OBJECTIVE: To investigate sex differences in cognitive performance of MS patients, in the context of brain pathology and disease burden. METHODS: Brain MRI, neurological examination, neuropsychological assessment (Brief International Cognitive Assessment in MS-BICAMS, and Paced Auditory Verbal Learning Test-PASAT), and patient-reported outcome questionnaires were performed/administered in 1052 MS patients. RESULTS: Females had higher raw scores in the Symbol Digit Modalities Test (SDMT) (57.0 vs. 54.0; p < 0.001) and Categorical Verbal Learning Test (CVLT) (63.0 vs. 57.0; p < 0.001), but paradoxically, females evaluated their cognitive performance by MS Neuropsychological Questionnaire as being worse (16.6 vs 14.5, p = 0.004). Females had a trend for a weaker negative correlation between T2 lesion volume and SDMT ([Formula: see text] = - 0.37 in females vs. - 0.46 in men; interaction p = 0.038). On the other hand, women had a trend for a stronger correlation between Brain Parenchymal Fraction (BPF) and a visual memory test (Spearman's [Formula: see text] = 0.31 vs. 0.21; interaction p = 0.016). All these trends were not significant after correction for false discovery rate. CONCLUSIONS: Although, females consider their cognition as worse, males had at a group level slightly worse verbal memory and information processing speed. However, the sex differences in cognitive performance were smaller than the variability of scores within the same sex group. Brain MRI measures did not explain the sex differences in cognitive performance among MS patients.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24007452
- 003
- CZ-PrNML
- 005
- 20240620104725.0
- 007
- ta
- 008
- 240412s2024 it f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s13760-023-02350-7 $2 doi
- 035 __
- $a (PubMed)37552396
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a it
- 100 1_
- $a Motyl, Jiri $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Multiple Sclerosis Center, Charles University and General University Hospital, Katerinska 30, 120 00, Prague, Czech Republic
- 245 10
- $a Brain MRI disease burden and sex differences in cognitive performance of patients with multiple sclerosis / $c J. Motyl, L. Friedova, R. Ganapathy Subramanian, M. Vaneckova, TA. Fuchs, J. Krasensky, J. Blahova Dusankova, E. Kubala Havrdova, D. Horakova, T. Uher
- 520 9_
- $a BACKGROUND: Although there is evidence that shows worse cognitive functioning in male patients with multiple sclerosis (MS), the role of brain pathology in this context is under-investigated. OBJECTIVE: To investigate sex differences in cognitive performance of MS patients, in the context of brain pathology and disease burden. METHODS: Brain MRI, neurological examination, neuropsychological assessment (Brief International Cognitive Assessment in MS-BICAMS, and Paced Auditory Verbal Learning Test-PASAT), and patient-reported outcome questionnaires were performed/administered in 1052 MS patients. RESULTS: Females had higher raw scores in the Symbol Digit Modalities Test (SDMT) (57.0 vs. 54.0; p < 0.001) and Categorical Verbal Learning Test (CVLT) (63.0 vs. 57.0; p < 0.001), but paradoxically, females evaluated their cognitive performance by MS Neuropsychological Questionnaire as being worse (16.6 vs 14.5, p = 0.004). Females had a trend for a weaker negative correlation between T2 lesion volume and SDMT ([Formula: see text] = - 0.37 in females vs. - 0.46 in men; interaction p = 0.038). On the other hand, women had a trend for a stronger correlation between Brain Parenchymal Fraction (BPF) and a visual memory test (Spearman's [Formula: see text] = 0.31 vs. 0.21; interaction p = 0.016). All these trends were not significant after correction for false discovery rate. CONCLUSIONS: Although, females consider their cognition as worse, males had at a group level slightly worse verbal memory and information processing speed. However, the sex differences in cognitive performance were smaller than the variability of scores within the same sex group. Brain MRI measures did not explain the sex differences in cognitive performance among MS patients.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a roztroušená skleróza $x komplikace $x diagnostické zobrazování $7 D009103
- 650 12
- $a kognitivní poruchy $x diagnóza $7 D003072
- 650 _2
- $a pohlavní dimorfismus $7 D012727
- 650 _2
- $a kognice $7 D003071
- 650 _2
- $a magnetická rezonanční tomografie $7 D008279
- 650 _2
- $a neuropsychologické testy $7 D009483
- 650 _2
- $a mozek $x diagnostické zobrazování $7 D001921
- 650 12
- $a kognitivní dysfunkce $7 D060825
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Friedová, Lucie, $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Multiple Sclerosis Center, Charles University and General University Hospital, Katerinska 30, 120 00, Prague, Czech Republic $d 1987- $7 xx0247500
- 700 1_
- $a Ganapathy Subramanian, Ranjani $u Department of Neurology, Buffalo Neuroimaging Analysis Center, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA
- 700 1_
- $a Vaneckova, Manuela $u Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
- 700 1_
- $a Fuchs, Tom A $u Department of Neurology, Buffalo Neuroimaging Analysis Center, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA
- 700 1_
- $a Krasensky, Jan $u Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
- 700 1_
- $a Blahova Dusankova, Jana $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Multiple Sclerosis Center, Charles University and General University Hospital, Katerinska 30, 120 00, Prague, Czech Republic
- 700 1_
- $a Kubala Havrdova, Eva $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Multiple Sclerosis Center, Charles University and General University Hospital, Katerinska 30, 120 00, Prague, Czech Republic
- 700 1_
- $a Horakova, Dana $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Multiple Sclerosis Center, Charles University and General University Hospital, Katerinska 30, 120 00, Prague, Czech Republic
- 700 1_
- $a Uher, Tomas $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Multiple Sclerosis Center, Charles University and General University Hospital, Katerinska 30, 120 00, Prague, Czech Republic. tomas.uher@vfn.cz $u Department of Physiotherapy, Faculty of Health Care, University of Presov, Prešov, Slovak Republic. tomas.uher@vfn.cz $1 https://orcid.org/0000000331609022 $7 xx0189534
- 773 0_
- $w MED00000090 $t Acta neurologica Belgica $x 2240-2993 $g Roč. 124, č. 1 (2024), s. 109-118
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37552396 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240412 $b ABA008
- 991 __
- $a 20240620104725 $b ABA008
- 999 __
- $a ok $b bmc $g 2081442 $s 1217219
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 124 $c 1 $d 109-118 $e 20230808 $i 2240-2993 $m Acta neurologica Belgica $n Acta Neurol Belg $x MED00000090
- GRA __
- $a NV18-08-00062 $p Ministerstvo Zdravotnictví Ceské Republiky
- GRA __
- $a RVO VFN 64165 $p Ministerstvo Zdravotnictví Ceské Republiky
- GRA __
- $a project Cooperatio LF1, research area Neuroscience $p Ministerstvo Školství, Mládeže a Tělovýchovy
- GRA __
- $a Programme EXCELES, ID project No LX22NPO5107 $p European Commission
- GRA __
- $a 1154218 $p Grantová Agentura, Univerzita Karlova
- LZP __
- $a Pubmed-20240412